Product Information
CANDESARTAN-HYDROCHLOROTHIAZIDE 32-12.5 MG TB is a generic product labeled by Macleods Pharmaceuticals Limited, priced at $1.0569 per EA under NDC 33342013215. Its NADAC has been published 515 times since Aug 17, 2016.
CANDESARTAN-HYDROCHLOROTHIAZIDE 32-12.5 MG TB
Candesartan Cilexetil and HydrochlorothiazideStrength
32; 12.5 mg/1; mg/1
Manufacturer
Macleods Pharmaceuticals LimitedNDC
33342013215
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
CANDESARTAN CILEXETIL; HYDROCHLOROTHIAZIDEApproval Type
Generic (ANDA)
FDA Application
ANDA204100On Market Since
3/7/2015
Pharmacological Classes
Price Statistics
The NADAC for CANDESARTAN-HYDROCHLOROTHIAZIDE 32-12.5 MG TB has been published 515 times since Aug 17, 2016, and over the history we have for it it has declined 66.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.0569 per EA |
|---|---|
| All-time high | $3.7501 (Jan 11, 2017) |
| All-time low | $0.7888 (Nov 20, 2024) |
| 52-week high | $1.2226 |
| 52-week low | $1.0214 |
| Median price | $1.7953 |
| Average price | $2.0255 |
| Largest weekly change | +48.6% (Aug 18, 2021) |
| Weeks tracked | 515 |
| Tracking since | Aug 17, 2016 |
Generic Alternatives
The matcher finds 2 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 2 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of CANDESARTAN-HYDROCHLOROTHIAZIDE 32-12.5 MG TB?
The current National Average Drug Acquisition Cost (NADAC) for CANDESARTAN-HYDROCHLOROTHIAZIDE 32-12.5 MG TB, manufactured by Macleods Pharmaceuticals Limited, is $1.0569 per EA (NDC 33342013215), effective Jun 24, 2026.
How has the price of CANDESARTAN-HYDROCHLOROTHIAZIDE 32-12.5 MG TB changed over time?
Over the history we have for it, the NADAC for CANDESARTAN-HYDROCHLOROTHIAZIDE 32-12.5 MG TB has declined 66.2%. It has been tracked across 515 weekly CMS publications since Aug 17, 2016.
What are the highest and lowest recorded NADAC prices for CANDESARTAN-HYDROCHLOROTHIAZIDE 32-12.5 MG TB?
Since Aug 17, 2016, the NADAC for CANDESARTAN-HYDROCHLOROTHIAZIDE 32-12.5 MG TB has ranged from a low of $0.7888 (Nov 20, 2024) to a high of $3.7501 (Jan 11, 2017), with a median of $1.7953 per EA.
Are there cheaper alternatives to CANDESARTAN-HYDROCHLOROTHIAZIDE 32-12.5 MG TB?
2 NADAC-published products share the same active ingredient, strength, and dosage form as CANDESARTAN-HYDROCHLOROTHIAZIDE 32-12.5 MG TB, but none are currently priced below it.
Who manufactures CANDESARTAN-HYDROCHLOROTHIAZIDE 32-12.5 MG TB?
CANDESARTAN-HYDROCHLOROTHIAZIDE 32-12.5 MG TB (NDC 33342013215) is labeled by Macleods Pharmaceuticals Limited, and CMS classifies it as a generic product.
Related Drugs
Same classification